Central Pacific Bank - Trust Division’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.71M Buy
3,417
+915
+37% +$439K 0.17% 132
2026
Q1
$1.23M Sell
2,502
-52
-2% -$28.2K 0.16% 147
2025
Q4
$1.48M Sell
2,554
-30
-1% -$17K 0.18% 127
2025
Q3
$1.25M Sell
2,584
-654
-20% -$304K 0.15% 146
2025
Q2
$1.31M Sell
3,238
-210
-6% -$87.8K 0.17% 135
2025
Q1
$1.72M Sell
3,448
-106
-3% -$57.4K 0.24% 109
2024
Q4
$1.85M Sell
3,554
-1,738
-33% -$956K 0.24% 100
2024
Q3
$3.27M Sell
5,292
-1,337
-20% -$791K 0.41% 53
2024
Q2
$3.67M Sell
6,629
-628
-9% -$360K 0.44% 41
2024
Q1
$4.19M Buy
+7,257
New +$4.07M 0.52% 31

Other funds holding TMO

Central Pacific Bank - Trust Division's TMO Position: Q2 2026 in Review

Central Pacific Bank - Trust Division increased its Thermo Fisher Scientific (TMO) stake by 37% in Q2 2026, buying an estimated $439K and bringing the position to 3,417 shares worth $1.71M. The position accounts for 0.17% of the portfolio, ranked #132.

Central Pacific Bank - Trust Division first reported a position in TMO in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.19M in Q1 2024. 1,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Central Pacific Bank - Trust Division held 3,417 shares of Thermo Fisher Scientific worth $1.71M as of Q2 2026.
  • Central Pacific Bank - Trust Division bought 915 Thermo Fisher Scientific shares in Q2 2026, an estimated $439K.
  • Thermo Fisher Scientific made up 0.17% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #132 holding.
  • Central Pacific Bank - Trust Division first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 10 quarters since.
  • Central Pacific Bank - Trust Division's Thermo Fisher Scientific position peaked at $4.19M in Q1 2024.
  • 1,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.